STAAR Surgical board urges shareholders to approve Alcon merger

Go back to STAAR Surgical board urges shareholders to approve Alcon merger

STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card

October 8, 2025 11:40 AM UTC

Comments on Glass Lewis Report

LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA) (STAAR), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL) for vision correction, today provided the following statement in response to a report issued by Glass, Lewis & Co., LLC (Glass Lewis) related to STAARs pending merger with Alcon (SIX/NYSE: ALC):

The STAAR Board of Directors and management team strongly disagree with the recommendation issued by Glass Lewis. Alcon is... More